How is Surging Incidence of Hospital-Acquired Infections Driving Infection Surveillance Solutions Industry?

The prevalence of hospital-acquired infections (HAI) has been growing rapidly, with HAIs becoming among the key cause of mortality and morbidity in hospitalized patients, as per the World Health Organization (WHO). These infections are caused primarily by bacteria. Strains of bacteria found in medical settings are more resistant to antibiotics those found outside the hospital, owing to the fact that antibiotics are utilized frequently in hospitals. According to the WHO, about 7 and 10 of every 100 patients ion developed and developing countries, respectively, who are hospitalized, acquire at least one HAI at any given time.

To learn  more about this report: https://bit.ly/30zsWpo

Attributed to this, the demand for infection surveillance at hospitals and other medical facilities is growing rapidly. Traditionally, the surveillance of HAIs was done by reviewing medical charts, ward rounds, and paper-based reports of microbiologic results. The analysis then was done by assembling hand-written data or entering the information into a computer database, manually. However, these methods are labor intensive, time-consuming, and quite inefficient for coping with the rising complexity of antibiotic resistance. Because of this, these methods are become obsolete and witnessing a shift to computer-based surveillance. Due to these factors, the global infection surveillance solutions market is predicted to advance at a considerable pace in the coming years.

In addition to this, a large number of key companies that offer web-based and on-premises solutions to track and check the spread of HAIs are present in the region. This being said, the demand for these solutions and associated services is predicted to increase substantially in the Asia-Pacific region, thereby making it the fastest growing infection surveillance solutions market in the years to come. This is attributed to the growing awareness and accessibility to advanced healthcare facilities, rising healthcare expenditure, surging incidence of HAIs, and expanding health insurance sector in the region.

Hence, the requirement for infection surveillance solutions is growing due to the rising prevalence of HAIs across the globe.

Read more: https://www.psmarketresearch.com/market-analysis/infection-surveillance-solutions-market

Read More

Hospital Infection Therapeutics Market Overview, Key Players, Growth and Future Scope

 Hospitals or other medical facilities are particularly associated with the treatment of diseases and the idea of getting infected with a pathogen while being in the hospitals may be quite foreign to a lot of people. However, hospital infections or hospital-acquired infections affect a lot of people; for example, according to the World Health Organization, of every 100 patients that are hospitalized, at any given time, about 10 in developing and 7 in developed counties will acquire at least one hospital infection. In addition to this, newborns especially are at a higher risk of suffering from healthcare associated disease in emerging economies.

To learn more about this report: https://bit.ly/3mfxHN8

Some of the hospital infections are catheter-associated urinary tract infections, central line-associated blood stream infections, hospital-acquired pneumonia, surgical site infections, Clostridium difficile infections, and ventilator-associated pneumonia. Much like any other infection, the risk of hospital infections depends on the patient’s immune status. Other than this, prevalence of several pathogens in the local community and infection control practices are also major factors on which hospital infection depend. Some of the major risk factors for these infections include longer hospital stays, older age, multiple underlying chronic illnesses, recent invasive procedures, immunosuppression, frequent encounters with healthcare facilities, and mechanical ventilatory support.

Geographically, North America has emerged as the largest hospital infection therapeutics market in the past few years, which is attributed to the enhanced healthcare infrastructure, increased awareness regarding healthcare, high ratio of hospitals in comparison to the population, surging aging population, and rising count of multi drug resistant microbial pathogens in the region. Apart from this, the demand for hospital infection therapeutics is also expected to increase significantly in the Asia-Pacific region because of the rising incidence of hospital infections and high requirement for therapeutic drugs in countries including China and India.

In conclusion, the demand for hospital infection therapeutics is growing due to the rising incidence of hospital infections.

Read more: https://www.psmarketresearch.com/market-analysis/hospital-infection-therapeutics-market

Read More

Digital Pathology of Great Importance for Geriatric Population

The prevalence of chronic diseases, including cancer, around the world has been increasing rapidly. According to the World Health Organization, cancer is among the leading causes of death, second-leading to be precise, globally, and led to about 8.8 million deaths in 2015. In addition to this, approximately 70% increase is expected to be witnessed in the number of new of cancer cases over the next two years. Like cancer, there are a number of chronic diseases which still cannot be cured and can only be managed with proper medication. 

In such cases, early detection of the disease is the key to get effective treatment for the management of the disease. Because of this, the demand for advanced technologies that can provide faster and more accurate and efficient diagnosis is rising. As per a report by P&S Intelligence, the global digital pathology market size is projected to advance at a significant pace in the years to come. The process of digitizing glass slides by making use of a whole slide image scanner for analyzing the digital images by utilizing an image viewer, such as a mobile device or computer monitor, is referred to as digital pathology.

To learn more about this report: https://bit.ly/3lhvGid

The geriatric population especially is widely utilizing teleconsultation services, as they make the management of chronic diseases easy and reduce the number of hospital visits. Other than this, the demand for this technology is also predicted to rise substantially for disease diagnosis in the near future because of the increasing incidence of bacterial and viral diseases. Geographically, North America is predicted to emerge as the largest digital pathology market in the years to come. This is owing to the rising healthcare expenditure and supportive government initiatives about the development of technologically innovative systems in the region. 

In conclusion, the demand for digital pathology technology is growing because of the surging prevalence of chronic diseases and increasing geriatric population.

Read more: https://www.psmarketresearch.com/market-analysis/digital-pathology-market

Read More

What are Latest Technologies in Embolotherapy Market?

More than 840,000 new liver cancer cases were diagnosed around the world in 2018, according to the World Cancer Research Fund (WCRF). Similarly, other severe diseases, such as kidney cancer, aneurysms, and varicose veins, are also increasing in prevalence due to genetic predisposition, environmental factors, sedentary lifestyle, obesity, and alcohol abuse. The treatment or management of many such issues requires deliberately blocking the blood vessels to reduce the risk of bleeding or hemorrhage or to starve the tumor of blood, by inserting a balloon.

Therefore, with the increasing prevalence of the above-mentioned disorders, the global embolotherapy market size is predicted to grow at an 8.0% CAGR during 2019–2024 (forecast period), to reach $4.8 billion in 2024 from $3 billion in 2018. In normal but life-threatening situations, a blood clot or mass breaks off from a part of the body and travels through the artery, thereby stopping the blood flow. But, because the same is now being done for managing a disease, the process is known as embolotherapy, meaning treatment by creating an embolus.

To learn more about this report: https://bit.ly/36T4px2

There are three primary approaches to the procedure: transarterial radioembolization (TARE)/selective internal radiation therapy (SIRT), transcatheter arterial embolization (TAE), and transarterial chemoembolization (TACE). Among these, TAE is the preferred approach, because it has a better toxicity profile than TACE and TARE/SIRT, which means less complication for the patients. During the procedure, the inner thigh is incised, and a catheter, which is a thin, flexible tube, is snaked through the femoral artery to a smaller artery near the site of the tumor or unhealthy tissue. Once the catheter is in place, tiny gelatin sponges are administered to stop the tumor’s blood supply.

Presently, North America witnesses the highest number of such procedures, as the incidence of various diseases which require these is rising in the continent. Moreover, the continent has the most advanced healthcare infrastructure in the world, and several improved embolic agents are being launched by biopharmaceutical companies. In the coming years, the most rapid embolotherapy market growth would be witnessed in Asia-Pacific (APAC), on account of the expansion in the pool of patients with advanced-stage cancers and rising expenditure on healthcare, which is leading to improvements in the medical infrastructure in the region.

Thus, with further advancements in the management methods for cancer and other advanced-stage diseases, which would lead to the availability of enhanced embolic agents, the preference for embolotherapy would keep surging.

Read more: https://www.psmarketresearch.com/market-analysis/embolotherapy-market

Read More

Growing Prevalence of Autoimmune Diseases to Fuel $10,012.9 Million Revenue in Autoimmune Disease Diagnostics Market in 2030

The rising incidence of autoimmune diseases, growing geriatric population, advent of novel biomarkers, increasing initiatives being taken by various government and private organizations for raising public awareness about autoimmune diseases, and the soaring strategic development projects and activities being launched by the market players are the key factors fueling the expansion of the global autoimmune disease diagnostics market. Furthermore, the market is predicted to attain a valuation of $10,012.9 million in 2030, exhibiting a CAGR of 8.5% from 2020 to 2030.

To learn more about this report: https://bit.ly/2UTn0DC

Based on product, the autoimmune disease diagnostics market is categorized into instruments and consumables and assay kits. Of these, the consumables and assay kits category is predicted to dominate the market in the future years, on account of the growing incidence of autoimmune diseases and the rising requirement for tests, such as enzyme-linked immunosorbent assay (ELISA), rheumatoid factor (RF) & anti-cyclic citrullinated peptide (CCP) antibody, and antinuclear antibody (ANA) immunofluorescence assay (IFA).

Globally, the North American autoimmune disease diagnostics market is predicted to exhibit lucrative growth in the upcoming years, owing to the rapid improvements in healthcare facilities and infrastructure, growing prevalence of autoimmune diseases, rising research activities, soaring geriatric population, and the existence of several leading market players in the region.

Browse full report at: https://www.psmarketresearch.com/market-analysis/autoimmune-disease-diagnostics-market-report

Some of the major market players are A. Menarini Diagnostics S.r.l., Bio-Rad Laboratories Inc., Adaltis S.r.l., Sigma Diagnostics Inc., ORGENTEC Diagnostika GmbH, PerkinElmer Inc., Inova Diagnostics, ELITech Group, Grifols S.A., HYCOR Biomedical, Exagen Inc., Cambridge Life Sciences Limited, Trinity Biotech plc, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Seramun Diagnostica GmbH, Siemens AG, bioMérieux S.A., Thermo Fisher Scientific Inc., Danaher Corporation, and Abbott Laboratories.

Read More

How is Rising Healthcare Expenditure Driving Exoskeleton Industry?

The global exoskeleton market size is projected to reach a value of $6,957.9 million by 2030. The primary factor leading to the growth of the market are the rising healthcare expenditure, increasing number of stroke cases and spinal cord injuries (SCIs), surge in the penetration of products in military and industrial operations, growing geriatric population, and rising job opportunities for disabled people.

To learn more about this report: https://bit.ly/331VB75

When component is taken into consideration, the exoskeleton market is classified into software and hardware, between which, the hardware classification held the larger share of the market in 2019. Exoskeletons consist of several hardware components and passive exoskeletons are particularly constructed using hardware parts, thereby leading to the growth of the classification. The hardware classification is further divided into control systems, power sources, actuators, and sensors. On the basis of mobility, the market is divided into mobile and stationary.

Geographically, the exoskeleton market was dominated by North America in 2019, and is region is predicted to contribute the largest revenue share to the market during the forecast period as well. Exoskeletons are extensively being used by military personnel and the healthcare sector. In addition to this, the regional market is growing because of the rising workforce of disabled people and increased availability of these products. The Asia-Pacific region is expected to register the fastest growth during the forecast period.

In conclusion, the increasing number of SCIs and stoke cases and rising healthcare expenditure are driving the growth of the market.

Read more: https://www.psmarketresearch.com/market-analysis/exoskeleton-market-forecast

Read More

What are Factors Contributing to Boom of Hospital Capacity Management Solutions Market in U.S.?

The rising demand for better healthcare facilities and rapid technological advancements in the healthcare sector are the major factors fuelling the demand for hospital capacity management solutions across the world. In addition to this, the mushrooming investments being made by several healthcare information technology (HIT) companies, soaring number of hospitals, and burgeoning need for integrated healthcare solutions are further pushing the demand for these solutions throughout the world. Propelled by these factors, the global hospital capacity management solutions market is expected to exhibit huge growth in the coming years.

To learn more about this report: https://bit.ly/3pIUKlh

Globally, North America and Europe are observing the highest usage of hospital capacity management solutions. This is primarily attributed to the increasing incidence of chronic diseases, soaring geriatric population, higher healthcare expenditure, and improving healthcare infrastructure in these regions. Moreover, the swift technological advancements in such software, the rising awareness regarding the applications of these solutions, and raging COVID epidemic are significantly contributing to the growing demand for these solutions in these regions. In North America and Europe, the U.S. and Italy, respectively, are witnessing the widest adoption of such solutions.

Latin America is another region witnessing a rapid rise in the adoption of these solutions. The main factors responsible for the boom of the hospital capacity management solutions market in LATAM are the increasing healthcare expenditure in the region, a major chunk of which is being spent on integrating IT functionalities in the medical sector. In this region, Brazil, on account of the rising support from numerous government organizations and developing healthcare infrastructure, is observing the highest implementation rate of hospital capacity management solutions.

Browse full report at: https://www.psmarketresearch.com/market-analysis/hospital-capacity-management-solutions-market

This Study Covers

• Historical and the present size of the hospital capacity management solutions market

• Major factors driving the market and their impact during the short, medium, and long terms

• Market restraints and their impact during the short, medium, and long terms

• Recent trends and evolving opportunities for the market participants

• Historical and the present size of the market segments and understand their comparative future potential

• Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings

Read More

Increasing Stem Cell Transplant Procedures Pushing Up Medical Gloves Sales in Asia-Pacific

With the recent outbreaks of various contagious diseases such as Middle East respiratory syndrome (MERS), Zika, severe acute respiratory syndrome (SARS), and Ebola, medical gloves are increasingly becoming extremely essential in healthcare operations. The outbreak of the COVID-19 (SARS CoV-2) pandemic has further pushed up the requirement for medical gloves, on account of their ability to prevent direct contact between persons, which is very essential for reducing the spread of the coronavirus.

Moreover, as the coronavirus is transmitted via direct contact and droplets, medical authorities and governments are increasingly mandating the use of medical gloves for people and healthcare workers. Researchers have found that protective medical equipment such as examination and surgical gloves reduce the spread of infection by a huge margin. Apart from contagious diseases, the increasing incidence of chronic diseases is also driving the sales of medical gloves across the world.

As per a study conducted by P&S Intelligence, the medical gloves market size is progressing at a 10.8% CAGR during the forecast period. The market has been registering growth due to the increasing risk of contagious diseases, rising volume of surgeries, surging geriatric population, growing healthcare spending, and increasing burden of chronic diseases across the globe.

Browse full report at: https://www.psmarketresearch.com/market-analysis/medical-gloves-market-report

As per the Organisation for Economic Co-operation and Development (OECD), in Japan, 5,032 stem cell transplant procedures were performed in 2010. Furthermore, the country witnessed a sharp rise in stem cell transplants in the next few years and recorded 5,609 procedures in 2015. Similarly, the number of transluminal coronary angioplasties increased in Australia from 37,600 to 45,517 from 2010 to 2017. This massive rise in the number of surgeries pushed up the sales of medical gloves in the country.

Therefore, it can be said without any doubt that the sales of medical gloves are predicted to rise enormously all over the world in the coming years, primarily because of the growing incidence of contagious and chronic diseases, the recent outbreak of the COVID-19 pandemic, and the rising awareness about hygiene among the people and healthcare practitioners.

Read More

How is Increasing Focus on Personalized Medicine Driving Cancer/Tumor Profiling Market?

Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass. For effective treatment, merely detecting the tumor within the body is not enough; its nature and the exact mutation which caused it also need to be studied.

Therefore, owing to the increasing number of people suffering from this disease and the high focus on deeply studying its various aspects, in order to device an effective therapy, the cancer/tumor profiling market is growing around the world. Several technologies, including quantitative polymerase chain reaction (QPCR), next-generation sequencing (NGS), in-situ hybridization (ISH), immunohistochemistry (IHC), and microarray, are used to study the tumors. Of these, NGS has been the most widely preferred till now, on account of its ability to quickly detect the sequencing of the deoxyribonucleic acid (DNA) in the genome.

To learn more about this report: https://bit.ly/38zw6gZ

Another important application area of cancer/tumor profiling is biomarker discovery. A biomarker is any substance against which the reaction of a disease is studied to determine its nature and severity. The most common biomarkers are antigens, which help detect the presence of infections. Seeing the rising complexities in cancer diagnosis, many biotechnology firms are coming up with innovative biomarkers for effective diagnosis. For instance, several biomarkers have been developed by Caris Life Sciences, by using ISH, IHC, and NGS, for the detection of translocation, protein expression, and fusion levels, analysis of gene amplification and deletion, and broad detection and rapid examination of DNA mutations.

Presently, the most productive cancer/tumor profiling market is North America, on account of the heavy investments in cancer research and therapy areas. Moreover, numerous technological advancements are taking place in the healthcare industry of the region, which are resulting in the introduction of more-advanced profiling techniques. In the region, the prevalence of common as well as rare cancers is rising, which is leading to increasing complexities in the diagnosis procedure. Asia-Pacific (APAC) would witness the fastest increase in the adoption of cancer/tumor profiling approach in the immediate future, due to the increasing government funding for cancer research and treatment, as well as rising cases of the disease.

Therefore, on account of the improvements in diagnosis methods, the demand for cancer/tumor profiling products and services will keep surging.

Read more: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market

Read More